Loading clinical trials...
Loading clinical trials...
Outcome of use of a novel Modulator of Oxidative Phosphorylation on kidney function in patients with Chronic Kidney Disease
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neukidney Inc.
NCT00977977 · Nephrotic Syndrome, Proteinuria, and more
NCT05196035 · Chronic Kidney Disease, Proteinuria
NCT04456816 · Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy
NCT07219121 · Proteinuria, Immunoglobulin A (IgA) Nephropathy, and more
NCT07368946 · Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder
Premier Kidney clinic
Pasadena, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions